The latest call
FetchingCanopy Growth Corporation reported on November 6, 2026. We are fetching the call transcript; its summary follows once the transcript is in.
CGC · Nasdaq · Healthcare · Drug Manufacturers Specialty and Generic
$0.56-2.2%Nov 13 close
Figures through September 30, 2026, from the 10-Q filed November 6, 2026
Just reported
From Canopy Growth Corporation's results release of November 6, 2026; its quarterly report has since been filed.
Actual
$81.4M
+22% y/y
+0.3% q/q
Guided
—
No guide given
Actual
-$0.10
Guided
—
No guide given
Actual
-$23M
| Measure | 3 months toSep 30, 2026 | 3 months toSep 30, 2025 | Change |
|---|---|---|---|
| Total Revenue | $57.1M | $46.8M | +22.03% |
| Profit | -$28.5M | -$3.5M | -717.48% |
| Profit per share | -$0.07 | -$0.01 | -400.00% |
| Free Cash Flow | -$10.9M | -$13.5M | +19.05% |
These are single quarters, not a trailing year — the figures elsewhere on this site cover twelve months and will be much larger. A seasonal business swings a long way between the two: ServiceNow earns $2.0B of free cash flow in its December quarter and $0.5B in its June one.
Compared against the same quarter a year earlier, not against an analyst forecast. A “beat” or “miss” needs a consensus estimate, which is licensed data we do not carry — and getting it wrong is worse than leaving it out.
Canopy Growth Corporation reported on November 6, 2026. We are fetching the call transcript; its summary follows once the transcript is in.
Releases land before the open or after the close, so the window runs from the close before the report day to the close of the session after it — the reaction is inside it either way.
Canopy Growth is a leading global company committed to bettering lives through cannabis. With a focus on cultivation excellence, quality, trust, innovation and disciplined execution, Canopy Growth is a consumer-centric company serving patients, consumers and partners alike. The Company’s portfolio of owned and licensed brands, including Tweed, 7ACRES, DOJA, Deep Space, DeeLish, Claybourne, MTL Cannabis, Low Key by MTL and R’belle, as well as category-defining Storz & Bickel, delivers innovative cannabis products to consumers across Canada and beyond. It is also Canada’s leading provider of medical cannabis services through Spectrum Therapeutics, Abba Medix, Apollo and Canada House Clinics. The Company also holds an unconsolidated, non-controlling interest in Canopy USA, which provides exposure to the U.S. THC market. Guided by its commitment to leadership, excellence, trust and innovation, Canopy Growth is working to shape a future where the plant is trusted for its ability to better lives.
The company’s own description, as it appears at the foot of the release.
The quote and the company description come from Canopy Growth Corporation’s Item 2.02 8-K filed November 6, 2026; the table is built from its quarterly reports. Read the release on EDGAR Share prices are split- and dividend-adjusted.
Guided
—
No guide given
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.